To our knowledge, this is the first study that delivers a detailed description of themethylation status of MIR21 in CD4+ T cells of MS patients andassociates it with the nearby risk allele, smoking, age, and changes in expressionof miR-21 and its target genes. This evidence concerns the gene CD4 and myeloid sarcoma.